PSMA2 Protein
Introduction
Psma2 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
<div class="infobox infobox-protein">
| | |
|---|---|
| Protein Name | Proteasome Subunit Alpha Type 2 |
| Gene | [PSMA2](/genes/psma2) |
| UniProt ID | [P25787](https://www.uniprot.org/uniprotkb/P25787) |
| Complex | 20S core particle of the proteasome |
| Localization | Cytoplasm and nucleus |
| Major Function | Alpha-ring architecture and substrate-gate control |
</div>
Overview
[PSMA2](/genes/psma2) encodes alpha type 2, a structural component of the 20S proteasome core. Together with [PSMA5](/proteins/psma5-protein) and other alpha subunits, PSMA2 forms the outer rings that regulate substrate entry into the proteolytic chamber.[@collins2017][@hipp2019] In [neurons](/entities/neurons), this gatekeeping function is critical for managing high protein-turnover demand and limiting accumulation of aggregation-prone proteins linked to [Alzheimer's Disease](/diseases/alzheimers-disease), [Parkinson's Disease](/diseases/parkinsons-disease), and related disorders.[@hipp2019][@keller2000]
Structural Biology And Proteasome Dynamics
...PSMA2 Protein
Introduction
Psma2 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
<div class="infobox infobox-protein">
| | |
|---|---|
| Protein Name | Proteasome Subunit Alpha Type 2 |
| Gene | [PSMA2](/genes/psma2) |
| UniProt ID | [P25787](https://www.uniprot.org/uniprotkb/P25787) |
| Complex | 20S core particle of the proteasome |
| Localization | Cytoplasm and nucleus |
| Major Function | Alpha-ring architecture and substrate-gate control |
</div>
Overview
[PSMA2](/genes/psma2) encodes alpha type 2, a structural component of the 20S proteasome core. Together with [PSMA5](/proteins/psma5-protein) and other alpha subunits, PSMA2 forms the outer rings that regulate substrate entry into the proteolytic chamber.[@collins2017][@hipp2019] In [neurons](/entities/neurons), this gatekeeping function is critical for managing high protein-turnover demand and limiting accumulation of aggregation-prone proteins linked to [Alzheimer's Disease](/diseases/alzheimers-disease), [Parkinson's Disease](/diseases/parkinsons-disease), and related disorders.[@hipp2019][@keller2000]
Structural Biology And Proteasome Dynamics
The 20S proteasome contains two alpha rings and two beta rings; catalytic cleavage occurs in beta subunits, while alpha subunits such as PSMA2 control access and structural integrity.[@collins2017][@rousseau2018] Conformational coupling between alpha rings and regulatory particles (19S/PA28) determines when ubiquitinated substrates are admitted for degradation.[@rousseau2018][@livneh2016]
PSMA2 therefore contributes indirectly to catalytic efficiency by:
Stabilizing alpha-ring interfaces.
Supporting gate transitions required for substrate translocation.
Enabling productive interaction with ATP-dependent regulatory caps.[@rousseau2018][@livneh2016]Defects in these structural steps can reduce effective proteasome throughput without direct mutation of catalytic beta chains.[@hipp2019][@rousseau2018]
Functional Role In Brain Proteostasis
In healthy brain tissue, PSMA2-containing proteasomes clear oxidized proteins, synaptic proteins requiring turnover, and damaged components generated during metabolic stress.[@hipp2019][@tai2008] This supports:
- Synaptic protein lifecycle control and neurotransmission stability.
- Adaptation to oxidative and inflammatory stress.
- Prevention of toxic oligomer persistence in vulnerable neuronal populations.[@hipp2019][@tai2008][@dantuma2014]
Proteasome function is closely integrated with lysosomal-autophagic systems; when [UPS](/mechanisms/ubiquitin-proteasome-system) activity drops, [autophagy](/entities/autophagy) compensation often increases but may fail in aged or diseased neurons.[@hipp2019][@thibaudeau2018]
Disease Mechanisms
Alzheimer's Disease
Proteasome dysfunction is repeatedly observed in AD [cortex](/brain-regions/cortex) and [hippocampus](/brain-regions/hippocampus), where it can exacerbate [tau](/proteins/tau) and amyloid-related proteotoxicity.[@keller2000][@dantuma2014] Reduced UPS flux can increase persistence of misfolded intermediates, reinforcing synaptic loss and inflammatory signaling.[@hipp2019][@thibaudeau2018]
Parkinson's Disease
In PD, [alpha-synuclein](/proteins/alpha-synuclein) pathology and mitochondrial stress converge with UPS insufficiency in dopaminergic neurons.[@keller2000][@mcnaught2004] Experimental proteasome inhibition induces features of nigrostriatal degeneration, supporting a mechanistic role for impaired proteasomal processing.[@mcnaught2004][@mcnaught2004a]
ALS/FTD And Systemic Proteostasis Stress
ALS/FTD models show broad proteostasis pressure involving RNA-binding protein aggregates, stress granules, and impaired protein clearance pathways.[@thibaudeau2018][@yerbury2016] PSMA2 should be interpreted as part of this shared system vulnerability architecture.
Translational Relevance
Potential applications for PSMA2-centered biology include:
Proteasome activity biomarkers (CSF/cellular assays) to monitor disease trajectory or treatment response.
Proteostasis therapies that combine UPS support with autophagy enhancement.
Precision strategies for early-stage disease where functional proteasome reserve may still be recoverable.[@hipp2019][@thibaudeau2018][@yerbury2016]A major translational challenge remains achieving sustained proteasome enhancement without unintended effects on normal signaling and immune-relevant protein processing.[@livneh2016][@thibaudeau2018]
See Also
- [PSMA2 Gene](/genes/psma2)
- [PSMA5 Protein](/proteins/psma5-protein)
- [Ubiquitin-Proteasome System](/mechanisms/ubiquitin-proteasome-system)
- [Autophagy-Lysosomal Pathway](/mechanisms/autophagy-lysosomal-pathway)
Background
The study of Psma2 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
External Links
- [PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
- [Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
- [Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data
References
[Collins GA, Goldberg AL, The Logic of the 26S Proteasome (2017)](https://doi.org/10.1016/j.cell.2017.01.036)
[Hipp MS, Kasturi P, Hartl FU, The proteostasis network and its decline in ageing (2019)](https://doi.org/10.1038/s41580-019-0101-y)
[Keller JN, Hanni KB, Markesbery WR, Impaired proteasome function in Alzheimer's disease (2000)](https://pubmed.ncbi.nlm.nih.gov/11483259/)
[Rousseau A, Bertolotti A, Regulation of proteasome assembly and activity in health and disease (2018)](https://doi.org/10.1038/nrm.2018.91)
[Livneh I, Cohen-Kaplan V, Cohen-Rosenzweig C, Avni N, Ciechanover A, The life cycle of the 26S proteasome: from birth, through regulation and function, and onto its death (2016)](https://doi.org/10.1080/10409238.2016.1189108)
[Tai HC, Schuman EM, Ubiquitin, the proteasome and protein degradation in neuronal function and dysfunction (2008)](https://pubmed.ncbi.nlm.nih.gov/18635427/)
[Dantuma NP, Bott LC, The ubiquitin-proteasome system in neurodegenerative diseases: precipitating factor, yet part of the solution (2014)](https://doi.org/10.3389/fnmol.2014.00070)
[Thibaudeau TA, Anderson RT, Smith DM, A common mechanism of proteasome impairment by neurodegenerative disease-associated oligomers (2018)](https://doi.org/10.1038/ncomms1117)
[McNaught KSP, Perl DP, Brownell AL, Olanow CW, Systemic exposure to proteasome inhibitors causes a progressive model of Parkinson's disease (2004)](https://pubmed.ncbi.nlm.nih.gov/16162839/)
[McNaught KSP, Olanow CW, Proteolytic stress: a unifying concept for the etiopathogenesis of Parkinson's disease (2004)](https://pubmed.ncbi.nlm.nih.gov/15482006/)
[Yerbury JJ, Ooi L, Dillin A, et al, Walking the tightrope: proteostasis and neurodegenerative disease (2016)](https://doi.org/10.1172/JCI120979)